Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiofrequency ablation in advanced head and neck cancer.

Literature DB >> 24061569

Radiofrequency ablation in advanced head and neck cancer.

Randall P Owen¹, Jane S Lee, Carl E Silver, Leif Bäck, Jonathan J Beitler, Alessandra Rinaldo, Bert W O'Malley, Missak Haigentz, Alfio Ferlito.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 24061569 DOI： 10.1007/s00405-013-2681-z

Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN： 0937-4477 Impact factor: 2.503

× No keyword cloud information.

22 in total

1. Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis.

Authors: A S Carney; A S Evans; S Mirza; A Psaltis
Journal: J Laryngol Otol Date: 2009-12-11 Impact factor: 1.469

2. Radiofrequency ablation of advanced head and neck cancer.

Authors: Randall P Owen; Sajid A Khan; Abdissa Negassa; Jonathan J Beitler; Jacqueline A Bello; Allan Brook; Joaquim Farinhas; Madhur K Garg; Missak Haigentz; Todd S Miller; Melody S Hsu; Thanjuvar S Ravikumar; Keivan Shifteh; Richard V Smith; Carl E Silver
Journal: Arch Otolaryngol Head Neck Surg Date: 2011-05

3. Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model.

Authors: Koichiro Saito; Koji Araki; Nishant Reddy; Wei Guang; Bert W O'Malley; Daqing Li
Journal: Head Neck Date: 2011-03 Impact factor: 3.147

4. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Authors: Jan B Vermorken; Jan Stöhlmacher-Williams; Irina Davidenko; Lisa Licitra; Eric Winquist; Cristian Villanueva; Paolo Foa; Sylvie Rottey; Krzysztof Skladowski; Makoto Tahara; Vasant R Pai; Sandrine Faivre; Cesar R Blajman; Arlene A Forastiere; Brian N Stein; Kelly S Oliner; Zhiying Pan; Bruce A Bach
Journal: Lancet Oncol Date: 2013-06-06 Impact factor: 41.316

Radiofrequency ablation in advanced head and neck cancer.

1. Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis.

2. Radiofrequency ablation of advanced head and neck cancer.

3. Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model.

4. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

5. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study.

6. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

7. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation.

Review 8. Radiofrequency ablation of liver tumours: systematic review.

9. Techniques for radiofrequency ablation of head and neck tumors.

10. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.

1. When is radiofrequency ablation not indicated in head and neck squamous cell carcinoma management?